Anti-TNFs in Early Puberty May Improve Growth in Pediatric IBD

They conclude: “The exact role that anti-TNF therapy plays in improving growth requires further study, including elucidation of more effective treatment strategies to reduce the inflammatory process and promote catch-up growth, so ensuring that young people with IBD can achieve their full growth potential.”

Dr. Cameron did not respond to an interview request by press time.

Reference

Cameron FL, Altowati MA, Rogers P, et al. Disease status and pubertal stage predict improved growth in anti-TNF therapy for pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2016 Sep 21. [Epub ahead of print]

Patients with autoimmune diseases, such as spondyloarthritis, are at risk of developing inflammatory bowel disease. Here are considerations for its management and treatment.

A 42-year-old man with a history of ulcerative colitis (UC), primary sclerosing cholangitis (PSC) and chronic sinusitis was referred to a rheumatologist to evaluate for a possible diagnosis of systemic vasculitis. This patient had developed new skin lesions, gingival hypertrophy and ulcerating tracheobronchitis, concerning for possible granulomatosis with polyangiitis (GPA). Since 1994, the patient had…

Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug option; others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and other medications used to…

Reckless approach versus missed opportunity?

Gut Feeling: A Comprehensive Look at the Pathogenesis, Management & Treatment of Inflammatory Bowel Disease

Case Report: Possible Overlapping Vasculitis & Ulcerative Colitis

Rheumatology Drugs at a Glance, Part 2: Psoriasis

TNF Blockade for SLE

Related Articles